arrow_back Back to App

Support for Rare Cancer Day: Raising Awareness and Research

This House Resolution supports designating September 30, 2024, as “Rare Cancer Day.” The aim is to highlight the challenges faced by patients with rare cancers and to promote early diagnosis and better treatment methods. Citizens may benefit from increased awareness and potentially earlier detection of these diseases.
Key points
Designation of “Rare Cancer Day” to increase public awareness.
Support for scientific research and the development of more effective treatments for rare cancers.
Emphasis on the need for early detection of rare cancers, which can improve patient outcomes.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_1521
Sponsor: Rep. Kelly, Mike [R-PA-16]
Process start date: 2024-09-27
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of September 30, 2024, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_1521.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-09-27.

What are the main provisions?

Key points include:

  • Designation of “Rare Cancer Day” to increase public awareness.
  • Support for scientific research and the development of more effective treatments for rare cancers.
  • Emphasis on the need for early detection of rare cancers, which can improve patient outcomes.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kelly, Mike [R-PA-16].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health